Last updated on September 2018

Study of ISIS 703802 in Subjects With Hypertriglyceridemia Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease


Brief description of study

This is a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the safety, including tolerability, of ISIS 703802 and to assess the efficacy of different doses and dosing regimens of ISIS 703802 on glucose and lipid metabolism, and liver fat in subjects with Hypertriglyceridemia, Type 2 Diabetes Mellitus (T2DM), and Nonalcoholic Fatty Liver Disease (NAFLD).

Clinical Study Identifier: NCT03371355

Contact Investigators or Research Sites near you

Start Over

Clinical Site

Clinical Site
Hamilton, ON Canada
  Connect »

Clinical Site

Clinical Site
Phoenix, AZ United States
  Connect »

Clinical Site

Clinical Site
Montclair, CA United States
  Connect »

Clinical Site

Clinical Site
Jupiter, FL United States
  Connect »

Clinical Site

Clinical Site
Port Saint Lucie, FL United States
  Connect »

Clinical Site

Clinical Site
Chicago, IL United States
  Connect »

Clinical Site

Clinical Site
Cincinnati, OH United States
  Connect »

Clinical Site

Clinical Site
Los Angeles, CA United States
  Connect »

Clinical Site

Clinical Site
Boca Raton, FL United States
  Connect »

Clinical Site

Clinical Site
Atlanta, GA United States
  Connect »

Clinical Site

Clinical Site
Louisville, KY United States
  Connect »

Clinical Site

Clinical Site
Austin, TX United States
  Connect »

Clinical Site

Clinical Site
Huntington Park, CA United States
  Connect »

Clinical Site

Clinical Site
Charleston, SC United States
  Connect »

Clinical Site

Clinical Site
Panorama City, CA United States
  Connect »

Clinical Site

Clinical Site
Hurst, TX United States
  Connect »

Clinical Site

Clinical Site
Toronto, ON Canada
  Connect »

Clinical Site

Clinical Site
San Antonio, TX United States
  Connect »

Clinical Site

Clinical Site
Chicoutimi, QC Canada
  Connect »

Clinical Site

Clinical Site
Carrollton, TX United States
  Connect »

Clinical Site

Clinical Site
Greensboro, NC United States
  Connect »

Clinical Site

Clinical Site
High Point, NC United States
  Connect »

Clinical Site

Clinical Sites
Chandler, AZ United States
  Connect »

Clinical Site

Clinical Site
Fountain Hills, AZ United States
  Connect »

Clinical Site

Clinical Site
Glendale, AZ United States
  Connect »

Clinical Site

Clinical Site
Mesa, AZ United States
  Connect »

Clinical Site

Clinical Site
Edina, MN United States
  Connect »

Clinical Site

Clinical Site
Dallas, TX United States
  Connect »

Clinical Site

Clinical Site
Layton, UT United States
  Connect »

Clinical Site

Clinical Site
Bridgeton, NJ United States
  Connect »

Clinical Site

Clinical Site
Montréal, QC Canada
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.